Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer

Both paclitaxel and S-1 are effective against gastric cancer, but the optimal regimen for combined chemotherapy with these drugs remains unclear. This phase I/II study was designed to determine the maximum tolerated dose (MTD), recommended dose (RD), dose-limiting toxicity (DLT), and objective respo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mochiki, E, Ohno, T, Kamiyama, Y, Aihara, R, Haga, N, Ojima, H, Nakamura, J, Ohsawa, H, Nakabayashi, T, Takeuchi, K, Asao, T, Kuwano, H
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2006
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360766/
https://ncbi.nlm.nih.gov/pubmed/17133268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603497
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados